Body Mass Index at Diagnosis and Breast Cancer-Specific Survival among Luminal and Non-Luminal Breast Cancers (n=1,559)
Hazard ratios and confidence intervals are weighted to account for stratified case-cohort study design with strata defined as IHC clinical subtype and adjusted for age, menopausal status, race/ethnicity, study, stage and chemotherapy.